Item Type | Name |
Concept
|
Lymphocytes
|
Concept
|
T-Lymphocytes, Cytotoxic
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
Concept
|
Lymphocyte Activation
|
Concept
|
Lymphocyte Depletion
|
Concept
|
CD8-Positive T-Lymphocytes
|
Concept
|
Lymphocyte Count
|
Concept
|
T-Lymphocytes, Regulatory
|
Concept
|
CD4-Positive T-Lymphocytes
|
Concept
|
B-Lymphocytes
|
Concept
|
T-Lymphocyte Subsets
|
Concept
|
Epitopes, T-Lymphocyte
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
Concept
|
T-Lymphocytes
|
Academic Article
|
A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression.
|
Academic Article
|
Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma.
|
Academic Article
|
Adoptive T-cell therapy for cancer: boutique therapy or treatment modality?
|
Academic Article
|
Genetic modification of T cell clones to improve the safety and efficacy of adoptive T cell therapy.
|
Academic Article
|
Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus.
|
Academic Article
|
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.
|
Academic Article
|
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.
|
Academic Article
|
In vivo tracking of tumor-specific T cells.
|
Academic Article
|
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.
|
Academic Article
|
Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
|
Academic Article
|
IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response.
|
Academic Article
|
Adoptive T-cell therapy of cancer.
|
Academic Article
|
Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
|
Academic Article
|
White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy.
|
Academic Article
|
Merkel cell polyomavirus-specific CD8? and CD4? T-cell responses identified in Merkel cell carcinomas and blood.
|
Academic Article
|
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.
|
Academic Article
|
Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype.
|
Academic Article
|
Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy.
|
Academic Article
|
Helper T cell-independent proliferation of CD8+ cytotoxic T lymphocytes transduced with an IL-1 receptor retrovirus.
|
Academic Article
|
Prospects for adoptive T cell therapy.
|
Academic Article
|
Genetic modification of T-cell clones for therapy of human viral and malignant diseases.
|
Academic Article
|
CD3- and CD28-dependent induction of PDE7 required for T cell activation.
|
Academic Article
|
Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.
|
Academic Article
|
Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses.
|
Academic Article
|
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.
|
Academic Article
|
Adoptive T cell therapy--immune monitoring and MHC multimers.
|
Academic Article
|
Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction.
|
Academic Article
|
Autoreactive T cells in healthy individuals.
|
Academic Article
|
Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells.
|
Academic Article
|
IL-21 mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes.
|
Academic Article
|
A multimodal targeting nanoparticle for selectively labeling T cells.
|
Academic Article
|
Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses.
|
Academic Article
|
Adoptive therapy using antigen-specific T-cell clones.
|
Academic Article
|
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine.
|
Academic Article
|
Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients.
|
Academic Article
|
HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway.
|
Academic Article
|
The effect of radiation on the immune response to cancers.
|
Academic Article
|
API5 confers tumoral immune escape through FGF2-dependent cell survival pathway.
|
Academic Article
|
Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends.
|
Academic Article
|
Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.
|
Academic Article
|
Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer.
|
Academic Article
|
Single step isolation and activation of primary CD3+ T lymphocytes using alcohol-dispersed electrospun magnetic nanofibers.
|
Academic Article
|
The use of endogenous T cells for adoptive transfer.
|
Academic Article
|
Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes.
|
Academic Article
|
NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.
|
Academic Article
|
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.
|
Academic Article
|
Ethanol-dispersed polymer nanofibers as a highly selective cell isolation and release platform for CD4 + T lymphocytes
|
Academic Article
|
T-cell therapy using interleukin-21-primed cytotoxic T-cell lymphocytes combined with cytotoxic T-cell lymphocyte antigen-4 blockade results in long-term cell persistence and durable tumor regression
|
Academic Article
|
Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment.
|
Academic Article
|
Interleukin-21 administration leads to enhanced antigen-specific T cell responses and natural killer cells in HIV-1 vaccinated mice.
|
Academic Article
|
T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression.
|
Academic Article
|
Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient.
|
Academic Article
|
SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity.
|
Academic Article
|
Adoptive T cell therapy: points to consider.
|
Academic Article
|
ImmTAC/Anti-PD-1 antibody combination to enhance killing of cancer cells by reversing regulatory T-cell-mediated immunosuppression.
|
Academic Article
|
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.
|
Academic Article
|
Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients.
|
Academic Article
|
CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity.
|
Academic Article
|
Systemic Interferon-? Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial.
|
Academic Article
|
Early Env-specific CTLs effectively suppress viral replication in SHIV controller macaques.
|
Academic Article
|
CD160 serves as a negative regulator of NKT cells in acute hepatic injury.
|
Academic Article
|
An Update on Adoptive T-Cell Therapy and Neoantigen Vaccines.
|
Academic Article
|
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.
|
Academic Article
|
Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer.
|
Academic Article
|
Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8+ T Cells to Memory T Cells.
|
Academic Article
|
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy.
|
Academic Article
|
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers.
|
Academic Article
|
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators.
|
Academic Article
|
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy.
|
Academic Article
|
Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.
|
Academic Article
|
Hypoxia acts as an environmental cue for the human tissue-resident memory T cell differentiation program.
|
Academic Article
|
Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs.
|
Academic Article
|
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.
|
Academic Article
|
Urinary T cells are detected in patients with immune checkpoint inhibitor-associated immune nephritis that are clonotypically identical to kidney T cell infiltrates.
|
Academic Article
|
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.
|
Academic Article
|
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modeling.
|
Academic Article
|
Nanofibrous MultiDomain Peptide Hydrogels Provide T Cells a 3D, Cytocompatible Environment for Cell Expansion and Antigen-Specific Killing.
|